loadpatents
name:-0.015629053115845
name:-0.013926029205322
name:-0.0061690807342529
Hideshima; Teru Patent Filings

Hideshima; Teru

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hideshima; Teru.The latest application filed is for "compounds for the degradation of stk4 and treatment of hematologic malignancies".

Company Profile
6.14.15
  • Hideshima; Teru - Brookline MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compounds for the degradation of STK4 and treatment of hematologic malignancies
Grant 11,447,467 - Buhrlage , et al. September 20, 2
2022-09-20
Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD38 inhibitor and methods of use thereof
Grant 11,337,975 - Quayle , et al. May 24, 2
2022-05-24
Compounds For The Degradation Of Stk4 And Treatment Of Hematologic Malignancies
App 20200331889 - Buhrlage; Sara ;   et al.
2020-10-22
Combinations Of Histone Deacetylase Inhibitors And Immunomodulatory Drugs
App 20200323849 - Quayle; Steven Norman ;   et al.
2020-10-15
Pharmaceutical Combinations Comprising A Histone Deacetylase Inhibitor And A Programmed Death-ligand 1 (pd-l1) Inhibitor And Met
App 20190282573 - Quayle; Steven ;   et al.
2019-09-19
Pharmaceutical Combinations Comprising A Histone Deacetylase Inhibitor And A Cd38 Inhibitor And Methods Of Use Thereof
App 20190282574 - Quayle; Steven ;   et al.
2019-09-19
Compositions and methods for treating multiple myeloma
Grant 10,302,644 - Hideshima , et al.
2019-05-28
Treatment of protein degradation disorders
Grant 10,172,905 - Anderson , et al. J
2019-01-08
Inhibitors of histone deacetylase
Grant 9,988,343 - Mazitschek , et al. June 5, 2
2018-06-05
Anti-proliferative compounds and uses thereof
Grant 9,969,679 - Anderson , et al. May 15, 2
2018-05-15
Compositions And Methods For Treating Multiple Myeloma
App 20170356917 - Hideshima; Teru ;   et al.
2017-12-14
Treatment of protein degradation disorders
Grant 9,572,854 - Anderson , et al. February 21, 2
2017-02-21
Inhibitors Of Histone Deacetylase
App 20160272579 - Mazitschek; Ralph ;   et al.
2016-09-22
Methods and agents for improving targeting of CD138 expressing tumor cells
Grant 9,446,146 - Daelken , et al. September 20, 2
2016-09-20
Treatment Of Protein Degradation Disorders
App 20160051619 - Anderson; Kenneth C. ;   et al.
2016-02-25
Anti-proliferative Compounds And Uses Thereof
App 20150191417 - Anderson; Kenneth C. ;   et al.
2015-07-09
Combinations Of Histone Deacetylase Inhibitors And Immunomodulatory Drugs
App 20150105358 - Quayle; Steven Norman ;   et al.
2015-04-16
Treatment of protein degradation disorders
Grant 8,999,289 - Anderson , et al. April 7, 2
2015-04-07
Methods and compositions for treating cancer using proteasome inhibitors
Grant 8,685,954 - Anderson , et al. April 1, 2
2014-04-01
Methods and Compositions for Treating Cancer Using Proteasome Inhibitors
App 20120214757 - Anderson; Kenneth C. ;   et al.
2012-08-23
Methods and compositions for treating cancer using proteasome inhibitors
Grant 8,026,230 - Anderson , et al. September 27, 2
2011-09-27
Methods And Agents For Improving Targeting Of Cd138 Expressing Tumor Cells
App 20090169570 - Daelken; Benjamin ;   et al.
2009-07-02
Treatment of protein degradation disorders
App 20060239909 - Anderson; Kenneth C. ;   et al.
2006-10-26
Multiple myeloma treatments
App 20060166947 - Anderson; Kenneth C. ;   et al.
2006-07-27
Methods and compositions for treating cancer using proteasome inhibitors
App 20050267037 - Anderson, Kenneth C. ;   et al.
2005-12-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed